• Home
  • News
  • Videos
  • Podcasts
  • Slides
  • Visual Abstracts
  • Topics
    • Acute Coronary Syndrome
    • Arrhythmia and Electrophysiology
    • Cardiovascular Imaging
    • Cardiovascular Intervention
    • Cardiovascular Prevention
    • Cerebrovascular Disease
    • Heart Failure
    • Peripheral Vascular Disease
    • Structural Heart Disease
    • Valvular Heart Disease
  • Conferences
    • SCAI 2018
    • ACC 2018
    • AHA 2017
    • ESC 2017
    • SCAI 2017
    • ACC 2017
Log In

Effects of Exenatide in Type 2 DM and CVD

Dr. C. Michael Gibson discusses the trial findings with Dr. Robert Mentz at AHA 2017

http://cardiologynownews.org/wp-content/uploads/temp/2114-2086.mp3

Podcast: Download

t f

More from AHA 2017

AHA 2017 Wrap-Up from a Pacific Rim Perspective

Medhat Abdelwahed, M.D.
By Medhat Abdelwahed, M.D.
January 28, 2018

Continued vs Interrupted NOAC at the time of Device Surgery

Medhat Abdelwahed, M.D.
By Medhat Abdelwahed, M.D.
January 24, 2018

Does High-Intensity Pitavastatin Therapy Improve Clinical Outcomes?

Medhat Abdelwahed, M.D.
By Medhat Abdelwahed, M.D.
January 24, 2018
Create an Account
Register for Cardiology Now News
CLICK TO REGISTER
Cardiology Now News is sponsored by the Baim Institute for Clinical Research and produced by the PERFUSE Study Group. Baim and PERFUSE are academic research organizations led by world class cardiovascular clinical trialists and opinion leaders.
Sign Up for Our Newsletter
Receive the latest news, interviews, podcasts directly to your inbox
About Cardiology Now | Editorial Board | Advertising | Terms of Use | Privacy Policy | Contact Us
© 2018 Baim Institute for Clinical Research, Inc. All rights reserved. Unauthorized use prohibited. The Baim Institute for Clinical Research is a qualified 501(c)(3) tax-exempt organization. This website is certified by Health On the Net Foundation. Click to verify.